Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021 WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial...

Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates Company intends to shorten fully-enrolled Phase 3 dermatomyositis trial to 28 weeks from 52 weeks following recent developments in competitive landscape; data now expected as early as the second...

Advantego Announces Third Quarter Financial Results Denver, CO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Advantego Corporation (OTCQB: ADGO) today announced financial results for the third quarter ended September 30, 2019. For the third quarter, Advantego...